FOR THE ATTENTION OF: CONTRACTORS PROVIDING FLU VACCINATION SERVICE
FOR HEALTH & SOCIAL CARE WORKERS
Dear Colleague,
As you will be aware the Community Pharmacy Flu Vaccination
service, for health and social care workers, was launched last week (w/c 28th
Sept).
A dedicated CPNI webpage (available here) has been created on our new website, which will be updated with all relevant correspondence, relating to this year’s Flu Vaccination service.
CPNI has also produced a support training video for service providers which can be assessed on our YouTube channel here.
We hope you find these resources useful and please share them
with your pharmacy team(s) involved in providing this year’s flu service.
If you have any queries in relation to this service, please contact Greg Miller, HSCB Pharmacy Adviser, (email: greg.miller@hscni.net) or alternatively the CPNI office.
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague,
Tolterodine 1mg Tablets – September 2020
Concessionary Price Re-Determination
The Department of Health and Social Care (DHSC) has re-determined the September 2020 concessionary price for Tolterodine 1mg tablets (56) as £12.90. All prescriptions for Tolterodine 1mg tablets submitted to BSO for payment for the dispensing month of September will be reimbursed at this new price.
This
has been updated on our website.
Kind regards,
Katherine
SENT
FOR AND BEHALF OF KATHERINE KIDD | Head of Pharmacy Development
ONLY FOR THE ATTENTION OF: CONTRACTORS PROVIDING FLU VACCINATION SERVICE FOR HEALTH & SOCIAL CARE WORKERS
Dear Colleague
HSCB CORRESPONDENCE: UPDATE – COMMUNITY PHARMACY SEASONAL FLU
VACCINATION SERVICE (CPFV) FOR HEALTH & SOCIAL CARE WORKERS (HSCWs)
Please find attached for your attention, correspondence from Joe
Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines
Management.
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
Dear Colleague,
Zoom Logon Details for CPNI Contractor Meeting at 7:30pm on Tuesday 6th October 2020
A lot has happened since the last
CPNI Contractor Meeting earlier this year in Templepatrick on 24th
February 2020. With the restrictions that came in as a result of COVID in
March, CPNI has supported and kept Contractors informed principally through our
regular COVID ContractorUpdate emails and via our web-site.
The last six months has seen the widespread adoption of online conferencing software to enable face to face interaction and CPNI will host a Contractor meeting using ZOOM software on Tuesday 6th October 2020 at 7.30pm.
Contractors are encouraged to attend
this virtual meeting to receive an update on the Community Pharmacy COVID
experience to date, Community Pharmacy Funding, the challenges the sector will
face over the coming weeks and months and the important role you and your teams
will play in defining patient care and the development of community pharmacy in
2021/22 and beyond.
Logon details for the Contractor
meeting are provided above.
I look forward to seeing you next
week.
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague,
Communication was sent out by Dr Michael McBride, Chief Medical Officer and Prof Ian Young, Chief Scientific Advisor here on 17th September 2020 which provided up-to-date information available with regard to minimising the risk of COVID-19 outbreaks in healthcare settings.
With the introduction of the Community Pharmacy Flu Vaccination Service or resuming audit visits, you and your pharmacy team(s) may potentially be visiting community settings, such as residential and nursing homes. The PHA have outlined key principles for HSC staff visiting community settings here which you may find useful.
Please share this advice with your pharmacy staff who may be
visiting a community setting to deliver pharmacy services.
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Dear Contractor
Update to Serious Shortage Protocols: Fluoxetine 40mg Capsules
The
Department of Health has released updated information (attached) on the Serious
Shortage Protocol (SSP) which was issued on 20 May 2020 in respect of
fluoxetine 40mg capsules.
Summary
The SSP was issued with an end date
of Monday 20 July 2020, which was extended until 2nd October 2020.
The SSP has now been further extended until Friday 16th October
2020.Details of the SSP are available on the BSO website and
can be accessed via this link: www.hscbusiness.hscni.net/services/3063.htm
Action
Contractors should:
Brief their dispensing teams
on the extension of the SSP.
CPNI colleagues will continue to support
contractors on these matters.
Kind regards
Mike
Sent
on behalf of Prof Mike Mawhinney | Head of Regulatory Affairs
Download
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
